Ezetimibe Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Lipid-regulating drugs | Cardiovascular System
Items (12m)
372
Total Quantity
6,601
NHS Cost
£1.2K
vs National Avg
-47.7%
MAPLE ACCESS PARTNERSHIP LLP prescribed 372 items of Ezetimibe over the last 12 months at a cost of £1,192 to the NHS. This is 47.7% below the national average prescribing rate. Ezetimibe is classified under Lipid-regulating drugs in the BNF.
Monthly Prescribing Trend
Jun 2026
26
Jun 2026
31
Jun 2026
33
Jun 2026
33
Jun 2026
32
Jun 2026
36
Jun 2026
30
Jun 2026
34
Jun 2026
36
Jun 2026
28
Jun 2026
28
Jun 2026
25
Prescribing Details
| Total Items | 372 |
|---|---|
| Total Quantity | 6,601 |
| Total NHS Cost | £1,192 |
| Presentations | 1 different forms |
| vs National Average | -47.7% |
Ezetimibe Prescribing Comparison
| This practice | 372 items |
|---|---|
| National average per practice | 711 items |
| Difference | -47.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.